Selank in St Mary's — Anxiolytic Peptide Research Guide
Selank peptide guide for St Mary's. Covers anxiolytic mechanisms, purity standards, COA verification, nasal administration, and how to source quality Selank for research.
For anyone in St Mary's trying to locate Selank, the foundational reality is that this compound is available only through an online research supply market. What this means for St Mary's researchers is that physical proximity is irrelevant compared to your ability to verify analytical documentation — and those verification methods are within reach of all serious researchers. The core quality markers for Selank are HPLC purity ≥98%, molecular identity established via mass spectrometry, and a bacterial endotoxin panel — all documented in a batch-matched Certificate of Analysis. This guide takes St Mary's researchers through that evaluation process and explains what quality documentation for Selank should look like.
Selank Mechanisms Explained
Selank belongs to a class of neuropeptides with documented activity in central nervous system models. Semax (ACTH4-7 Pro-Gly-Pro) is a synthetic analogue of adrenocorticotropic hormone fragments, and has been shown in animal and some human research to increase brain-derived neurotrophic factor (BDNF) expression — a key signal for neuroplasticity, neuronal survival, and synaptic strengthening. Selank, a synthetic analogue of the endogenous peptide tuftsin, has been shown to modulate GABAergic transmission and influence enkephalinase activity, producing anxiolytic and nootropic effects in rodent models. For researchers in St Mary's studying cognitive biology and neuropeptide pharmacology, these compounds represent a productive area where mechanistic specificity is well-characterized.
How to Source Selank — Vendor Guide
Vetting Selank vendors requires starting from the COA: access the batch-specific certificate before placing an order, not after. Mass spectrometry in the COA confirms that the main HPLC peak is actually Selank and not a different peptide of similar polarity — HPLC purity alone does not confirm what the compound actually is. Red flags in Selank vendor evaluation: prices far under typical market pricing, vague sourcing information, no community presence, and COAs that omit endotoxin testing. The powdered lyophilised form of Selank is always preferable to liquid pre-made solutions — lyophilised powder stays viable for years at −20°C, while liquid preparations degrade within weeks even when refrigerated.
Order Selank — ships to St Mary's
COA-verified · International tracking · Research grade
All use of Selank in St Mary's or anywhere must be research use only — this compound is not approved for human therapeutic use, and all handling should adhere to research compound handling standards. Temperature excursions — even brief warming above recommended storage temperature — can compromise product integrity without visible changes; always use only material shipped with appropriate cold protection. Bacterial endotoxin contamination is the primary safety concern specific to research peptides — verify endotoxin testing is present in the lot-matched certificate before any injectable research application. For any individual considering Selank outside a formal research context: seek medical advice first — this compound is not approved for human use and its safety characterisation does not match that of regulated drugs.
Frequently Asked Questions
Is Selank similar to Semax?
Semax and Selank are both synthetic neuropeptides developed by the same Russian institution with overlapping clinical applications. They have distinct mechanisms: Semax primarily upregulates BDNF and acts on ACTH receptor systems; Selank primarily modulates GABAergic transmission and enkephalin activity. They are sometimes studied in combination.
How does Selank produce anxiolytic effects?
Selank's anxiolytic mechanism is thought to involve modulation of GABAergic transmission (similar but distinct to benzodiazepines), inhibition of enkephalinase (extending the activity of endogenous enkephalins), and BDNF expression modulation. The multi-mechanism profile distinguishes it from single-target anxiolytics.
What is the administration route for Selank research?
Like Semax, Selank is primarily studied via intranasal administration for CNS applications, utilizing olfactory nerve transport to bypass the blood-brain barrier. The solution concentration used in research is typically 0.15% (1.5mg/mL). Subcutaneous administration has also been studied in animal models.
What is Selank?
Selank is a synthetic analogue of tuftsin (a tetrapeptide fragment of immunoglobulin G) with three additional amino acids for stability. It has been studied for anxiolytic effects, cognitive enhancement, and GABAergic system modulation. Like Semax, it was developed by the Institute of Molecular Genetics in Russia and has a clinical history in Russian medicine.
